HKPD Stock Summary and Trading Ideas (Cellyan Biotechnology Co. - Class A | NASDAQ:HKPD)

Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Cellyan Biotechnology Co. - Class A trades on the NASDAQ stock market under the symbol HKPD.

As of July 22, 2026, HKPD stock price declined to $0.35 with 1,862,571 million shares trading.

HKPD has a beta of 1.61, meaning it tends to be more sensitive to market movements. HKPD has a correlation of 0.05 to the broad based SPY ETF.

HKPD has a market cap of $8.29 million. This is considered a Sub-Micro Cap stock.

HKPD has underperformed the market in the last year with a price return of -74.1% while the SPY ETF gained +20.1%. HKPD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -48.9% and -17.4%, respectively, while the SPY returned +6.4% and 0.0%, respectively.

HKPD support price is $.34 and resistance is $.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HKPD shares will trade within this expected range on the day.